产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1350624-75-7

英文名称

-

别名

Margetuximab;Research Grade Margetuximab(DHC09604);Margetuximab (anti-HER2);Research Grade Margetuximab

用途

Margetuximab is an Fc-engineered, HER2-targeted monoclonal antibody approved by the U.S. FDA (as margetuximab-cmkb, Margenza) in combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease. It binds to the extracellular domain of the human epidermal growth factor receptor 2 (HER2), inhibits tumor cell proliferation, reduces shedding of the HER2 extracellular domain, and mediates antibody-dependent cellular cytotoxicity (ADCC).

安全信息

评论 0
我是晶智Agent,
您的化学小助手